130 related articles for article (PubMed ID: 4078096)
21. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
Highet AS
Br J Dermatol; 1980 Mar; 102(3):358-60. PubMed ID: 7370185
[No Abstract] [Full Text] [Related]
22. A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.
Leslie KS; Gaffney K; Ross CN; Ridley S; Barker TH; Garioch JJ
Clin Exp Dermatol; 2003 Sep; 28(5):496-8. PubMed ID: 12950336
[TBL] [Abstract][Full Text] [Related]
23. Interferon alpha 2a therapy for urticarial vasculitis with angioedema apparently following hepatitis A infection.
Matteson EL
J Rheumatol; 1996 Feb; 23(2):382-4. PubMed ID: 8882052
[TBL] [Abstract][Full Text] [Related]
24. Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
Micheletti RG; Pagnoux C; Tamura RN; Grayson PC; McAlear CA; Borchin R; Krischer JP; Merkel PA;
Trials; 2020 Apr; 21(1):362. PubMed ID: 32345372
[TBL] [Abstract][Full Text] [Related]
25. In Urticarial Vasculitis, Long Disease Duration, High Symptom Burden, and High Need for Therapy Are Linked to Low Patient-Reported Quality of Life.
Bonnekoh H; Jelden-Thurm J; Butze M; Krause K; Maurer M; Kolkhir P
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2734-2741.e7. PubMed ID: 35868452
[TBL] [Abstract][Full Text] [Related]
26. Urticarial vasculitis: a unique presentation.
Stigall LE; Sigmon JR; Leicht SS
South Med J; 2009 May; 102(5):531-3. PubMed ID: 19373142
[TBL] [Abstract][Full Text] [Related]
27. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
Holtman JH; Neustadt DH; Klein J; Callen JP
J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
[TBL] [Abstract][Full Text] [Related]
28. Neutrophilic urticarial dermatosis: A review.
Gusdorf L; Lipsker D
Ann Dermatol Venereol; 2018 Dec; 145(12):735-740. PubMed ID: 30224079
[TBL] [Abstract][Full Text] [Related]
29. Urticarial vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia.
Nishijima C; Hatta N; Inaoki M; Sakai H; Takehara K
Eur J Dermatol; 1999; 9(1):54-6. PubMed ID: 9920991
[TBL] [Abstract][Full Text] [Related]
30. A Case of Erythema Elevatum Diutinum With Pancytopenia: Focus on Dapsone-Induced Hematologic Side Effects and Colchicine as a Safe Treatment Option.
Kocatürk E; Memet B; Topal IO; Yüksel T; Ülkümen PK; Kızıltaç U
J Drugs Dermatol; 2015 Oct; 14(10):1090-2. PubMed ID: 26461818
[No Abstract] [Full Text] [Related]
31. [Systemic urticarias].
Hachulla E
Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S53-68. PubMed ID: 12843810
[TBL] [Abstract][Full Text] [Related]
32. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases.
Fredenberg MF; Malkinson FD
J Am Acad Dermatol; 1987 Apr; 16(4):772-8. PubMed ID: 3571541
[TBL] [Abstract][Full Text] [Related]
33. [Urticaria-vasculitis with bullous eruptions in visceral lupus erythematosus].
Faulhaber G; Lechner W
Z Hautkr; 1987 Jun; 62(11):839-40, 843-4. PubMed ID: 3303712
[TBL] [Abstract][Full Text] [Related]
34. Treatment of urticarial vasculitis: A systematic review.
Kolkhir P; Grakhova M; Bonnekoh H; Krause K; Maurer M
J Allergy Clin Immunol; 2019 Feb; 143(2):458-466. PubMed ID: 30268388
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate for urticarial vasculitis.
Stack PS
Ann Allergy; 1994 Jan; 72(1):36-8. PubMed ID: 8291748
[TBL] [Abstract][Full Text] [Related]
36. [Hypocomplementemic urticarial vasculitis].
Jachiet M; Flageul B; Bouaziz JD; Bagot M; Terrier B;
Rev Med Interne; 2018 Feb; 39(2):90-98. PubMed ID: 28457680
[TBL] [Abstract][Full Text] [Related]
37. A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab.
Nucera E; Basta F; Buonomo A; Mezzacappa S; Margiotta DP; Antonelli Incalzi R; Schiavino D
J Investig Allergol Clin Immunol; 2017; 27(6):382-384. PubMed ID: 29199964
[No Abstract] [Full Text] [Related]
38. Treatment of vasculitis with chlorpromazine and dapsone.
Asghar SS; Westerhof W; Das PK; Jansen FC; Cormane RH
Arch Dermatol Res; 1985; 277(6):504-6. PubMed ID: 4051562
[No Abstract] [Full Text] [Related]
39. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features.
Criado RF; Criado PR; Martins JE; Valente NY; Michalany NS; Vasconcellos C
J Dermatolog Treat; 2008; 19(2):92-6. PubMed ID: 18484427
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis.
Worm M; Sterry W; Kolde G
Br J Dermatol; 2000 Dec; 143(6):1324. PubMed ID: 11122046
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
